These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 9187408)
1. Simple, rapid and sensitive method for the determination of indomethacin in plasma by high-performance liquid chromatography with ultraviolet detection. Sato J; Amizuka T; Niida Y; Umetsu M; Ito K J Chromatogr B Biomed Sci Appl; 1997 Apr; 692(1):241-4. PubMed ID: 9187408 [TBL] [Abstract][Full Text] [Related]
2. Liquid-chromatographic determination of indomethacin in blood from newborns with patent ductus arteriosus. Ou CN; Frawley VL Clin Chem; 1984 Jun; 30(6):898-901. PubMed ID: 6723048 [TBL] [Abstract][Full Text] [Related]
3. A rapid and sensitive microscale HPLC method for the determination of indomethacin in plasma of premature neonates with patent ductus arteriousus. Al Za'abi MA; Dehghanzadeh GH; Norris RL; Charles BG J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):364-7. PubMed ID: 16326151 [TBL] [Abstract][Full Text] [Related]
4. Determination of indomethacin in plasma by micellar electrokinetic chromatography with UV detection for premature infants with patent ducts arteriosus. Lin SJ; Chen YR; Su YH; Tseng HI; Chen SH J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jan; 830(2):306-13. PubMed ID: 16321577 [TBL] [Abstract][Full Text] [Related]
5. Determination of indomethacin and mefenamic acid in plasma by high-performance liquid chromatography. Niopas I; Mamzoridi K J Chromatogr B Biomed Appl; 1994 Jun; 656(2):447-50. PubMed ID: 7987501 [TBL] [Abstract][Full Text] [Related]
6. Improved high-performance liquid chromatographic method for the determination of indomethacin in plasma. Johnson AG; Ray JE Ther Drug Monit; 1992 Feb; 14(1):61-5. PubMed ID: 1546391 [TBL] [Abstract][Full Text] [Related]
7. Plasma indomethacin levels in preterm newborn infants with symptomatic patent ductus arteriosus--clinical and echocardiographic assessments of response. Alpert BS; Lewins MJ; Rowland DW; Grant MJ; Olley PM; Soldin SJ; Swyer PR; Coceani F; Rowe RD J Pediatr; 1979 Oct; 95(4):578-82. PubMed ID: 480038 [No Abstract] [Full Text] [Related]
8. Simple, rapid and sensitive reversed-phase high-performance liquid chromatographic method for the determination of mefenamic acid in plasma. Sato J; Owada E; Ito K; Niida Y; Wakamatsu A; Umetsu M J Chromatogr; 1989 Aug; 493(1):239-43. PubMed ID: 2778018 [No Abstract] [Full Text] [Related]
9. A high performance liquid chromatography method for the analysis of total and free indomethacin in serum. Roberts I; Smith IM Ann Clin Biochem; 1987 Mar; 24 ( Pt 2)():167-71. PubMed ID: 3592566 [TBL] [Abstract][Full Text] [Related]
10. Indomethacin treatment in small versus large premature infants with ductus arteriosus. Comparison of plasma indomethacin concentration and clinical response. Yeh TF; Luken J; Raval D; Thalji A; Carr I; Pildes RS Br Heart J; 1983 Jul; 50(1):27-30. PubMed ID: 6860508 [TBL] [Abstract][Full Text] [Related]
11. [Determination of plasma drug concentration and bioavailability of indomethacin controlled release capsule by high performance liquid chromatography]. Zhang D; Zeng J; Bianba-Cangjue ; Jiang X Se Pu; 1997 Nov; 15(6):515-7. PubMed ID: 15739336 [TBL] [Abstract][Full Text] [Related]
12. Indomethacin therapy for patent ductus arteriosus in premature infants: efficacy of a dosing strategy based on a second-dose peak plasma indomethacin level and estimated plasma indomethacin levels. O'Donovan DJ; Fernandes CJ; Nguyen NY; Adams K; Adams JM Am J Perinatol; 2004 May; 21(4):191-7. PubMed ID: 15168317 [TBL] [Abstract][Full Text] [Related]
13. Indomethacin therapy in premature infants with patent ductus arteriosus--determination of therapeutic plasma levels. Yeh TF; Achanti B; Patel H; Pildes RS Dev Pharmacol Ther; 1989; 12(4):169-78. PubMed ID: 2766920 [TBL] [Abstract][Full Text] [Related]
14. Decreased plasma glucose following indomethacin therapy in premature infants with patent ductus arteriosus. Yeh TF; Raval D; Lilien LD; Srinivasan G; Pildes RS Pediatr Pharmacol (New York); 1982; 2(3):171-7. PubMed ID: 6761637 [TBL] [Abstract][Full Text] [Related]
15. Plasma indomethacin assay using high-performance liquid chromatography-electrospray-tandem mass spectrometry: application to therapeutic drug monitoring and pharmacokinetic studies. Taylor PJ; Jones CE; Dodds HM; Hogan NS; Johnson AG Ther Drug Monit; 1998 Dec; 20(6):691-6. PubMed ID: 9853990 [TBL] [Abstract][Full Text] [Related]
16. Indomethacin therapy in infants with advanced postnatal age and patent ductus arteriosus. Achanti B; Yeh TF; Pildes RS Clin Invest Med; 1986 Nov; 9(4):250-3. PubMed ID: 3802612 [TBL] [Abstract][Full Text] [Related]
17. Introduction of plasma indomethacin level monitoring and evaluation of an effective threshold level in very low birth weight infants with symptomatic patent ductus arteriosus. Seyberth HW; Knapp G; Wolf D; Ulmer HE Eur J Pediatr; 1983 Dec; 141(2):71-6. PubMed ID: 6363085 [TBL] [Abstract][Full Text] [Related]